
Massachusetts Lawmakers Prioritize Health Policy
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
By Jen Sorensen and via Kevin Outterson. @afrakt
I write this column at 40,000 feet. I’m returning from the sixth annual meeting of the International Society for the Study of Drug Policy. That’s
I know this is outside of my usual wheelhouse, but I’ve been playing with the FRED Plug-In for Excel (h/t Jared Bernstein). It has tons
Kinda short, but here it is: Bankruptcy as Implicit Health Insurance, by Neale Mahoney (The National Bureau of Economic Research) This paper examines the implicit
OK, I’ve heard you. You want a comment preview button so you can check your comment before submitting it. It’s a good idea! The blog
The House just passed their version of PDUFA V, H.R. 5651, by a vote of 387-5, including new incentives for antibiotics and antifungals. I’ve commented
Longtime readers of the blog know that I can easily go off on a rant about how survival rates are not the same as mortality
What now seems like ages ago (but was only in early April), Joe Doyle and colleagues published an NBER paper finding, in their words, that
Jamie Love has a very thoughtful post on the use and misuse of the term “counterfeit” when applied to drugs, calling both the NYT and
I’ve discussed physician salaries many times on this blog. No topic brings me hate mail faster. I don’t bring it up because I believe that
I just finished, and enjoyed, Tyler Cowen’s An Economist Gets Lunch. It’s chock full of fun guidance for anyone with an adventurous spirit seeking better food.
My latest publication, coauthored by Steve Pizer and Roger Feldman, addresses the question posed in the title of this post. Though I encourage you to